131 related articles for article (PubMed ID: 14765730)
1. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats.
Mealey KL; Peck KE; Bennett BS; Sellon RK; Swinney GR; Melzer K; Gokhale SA; Krone TM
J Vet Intern Med; 2004; 18(1):43-6. PubMed ID: 14765730
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.
Hoffman SB; Yoder AR; Trepanier LA
J Vet Pharmacol Ther; 2002 Jun; 25(3):189-93. PubMed ID: 12081614
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of buspirone extended-release tablets: a single-dose study.
Sakr A; Andheria M
J Clin Pharmacol; 2001 Jul; 41(7):783-9. PubMed ID: 11452712
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
Jagannathan V; Venitz J
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range.
Dockens RC; Salazar DE; Fulmor IE; Wehling M; Arnold ME; Croop R
J Clin Pharmacol; 2006 Nov; 46(11):1308-12. PubMed ID: 17050795
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.
Willis-Goulet HS; Schmidt BA; Nicklin CF; Marsella R; Kunkle GA; Tebbett IR
Vet Dermatol; 2003 Apr; 14(2):83-9. PubMed ID: 12662265
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of oral amitriptyline in horses.
Recchi L; Alvariza S; Benech A; Ruiz N; José Estradé M; Suarez G; Crosignani N
J Vet Pharmacol Ther; 2020 Jul; 43(4):381-384. PubMed ID: 32339314
[TBL] [Abstract][Full Text] [Related]
8. Absorption of transdermal and oral cyclosporine in six healthy cats.
Miller R; Schick AE; Boothe DM; Lewis TP
J Am Anim Hosp Assoc; 2014; 50(1):36-41. PubMed ID: 24216498
[TBL] [Abstract][Full Text] [Related]
9. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies.
Shumilov M; Touitou E
Int J Pharm; 2010 Mar; 387(1-2):26-33. PubMed ID: 19961912
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the in vivo effects of intravenous lipid emulsion on blood drug concentration and haemodynamics following oro-gastric amitriptyline overdose.
Perichon D; Turfus S; Gerostamoulos D; Graudins A
Clin Toxicol (Phila); 2013 May; 51(4):208-15. PubMed ID: 23530458
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of buspirone following oral administration to rhesus monkeys.
Marathe PH; Shen F; Markham P; Greene DS
J Pharm Pharmacol; 1999 May; 51(5):601-7. PubMed ID: 10411220
[TBL] [Abstract][Full Text] [Related]
12. Lack of pharmacokinetic interaction between buspirone and haloperidol in patients with schizophrenia.
Huang HF; Jann MW; Wei FC; Chang TP; Chen JS; Juang DJ; Lin SK; Lam YW; Chien CP; Chang WH
J Clin Pharmacol; 1996 Oct; 36(10):963-9. PubMed ID: 8930784
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug.
Mahmood I; Sahajwalla C
Clin Pharmacokinet; 1999 Apr; 36(4):277-87. PubMed ID: 10320950
[TBL] [Abstract][Full Text] [Related]
14. Amitriptyline absorption in a patient with short bowel syndrome.
Robbins B; Reiss RA
Am J Gastroenterol; 1999 Aug; 94(8):2302-4. PubMed ID: 10445571
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats.
Ciribassi J; Luescher A; Pasloske KS; Robertson-Plouch C; Zimmerman A; Kaloostian-Whittymore L
Am J Vet Res; 2003 Aug; 64(8):994-8. PubMed ID: 12926591
[TBL] [Abstract][Full Text] [Related]
16. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
17. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
[TBL] [Abstract][Full Text] [Related]
18. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
Abaut AY; Chevanne F; Le Corre P
Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline.
Gupta SK; Shah JC; Hwang SS
Br J Clin Pharmacol; 1999 Jul; 48(1):71-8. PubMed ID: 10383563
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box-Behnken statistical design.
Gannu R; Palem CR; Yamsani SK; Yamsani VV; Yamsani MR
AAPS PharmSciTech; 2010 Jun; 11(2):976-85. PubMed ID: 20517714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
